These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 23772082)

  • 1. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.
    Bourré-Tessier J; Clarke AE; Kosinski M; Mikolaitis-Preuss RA; Bernatsky S; Block JA; Jolly M
    Lupus; 2014 Dec; 23(14):1452-9. PubMed ID: 25081500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines.
    Navarra SV; Tanangunan RM; Mikolaitis-Preuss RA; Kosinski M; Block JA; Jolly M
    Lupus; 2013 Mar; 22(3):262-7. PubMed ID: 23340995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turkish lupusPRO: cross-cultural validation study for lupus.
    Kaya A; Goker B; Cura ES; Tezcan ME; Tufan A; Mercan R; Bitik B; Haznedaroglu S; Ozturk MA; Mikolaitis-Preuss RA; Block JA; Jolly M
    Clin Rheumatol; 2014 Aug; 33(8):1079-84. PubMed ID: 23934384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spanish LupusPRO: cross-cultural validation study for lupus.
    Jolly M; Toloza S; Block J; Mikolaitis R; Kosinski M; Wallace D; Durran-Barragan S; Bertoli A; Blazevic I; Vilá L; Cooray D; Moldovan I; Katsaros E; Weisman M; Torralba KM; Alarcón G
    Lupus; 2013 Apr; 22(5):431-6. PubMed ID: 23554032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients.
    Elkaraly NE; Nasef SI; Omar AS; Fouad AM; Jolly M; Mohamed AE
    Lupus; 2020 Nov; 29(13):1727-1735. PubMed ID: 32878556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus.
    Pinto B; Jolly M; Dhooria A; Grover S; Raj JM; Devilliers H; Sharma A
    Lupus; 2019 Nov; 28(13):1534-1540. PubMed ID: 31635557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus.
    Mok CC; Kosinski M; Ho LY; Chan KL; Jolly M
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):297-304. PubMed ID: 25156199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.
    Azizoddin DR; Weinberg S; Gandhi N; Arora S; Block JA; Sequeira W; Jolly M
    Lupus; 2018 Apr; 27(5):728-737. PubMed ID: 29087259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific patient reported outcome tools for systemic lupus erythematosus.
    Jolly M; Pickard AS; Block JA; Kumar RB; Mikolaitis RA; Wilke CT; Rodby RA; Fogg L; Sequeira W; Utset TO; Cash TF; Moldovan I; Katsaros E; Nicassio P; Ishimori ML; Kosinsky M; Merrill JT; Weisman MH; Wallace DJ
    Semin Arthritis Rheum; 2012 Aug; 42(1):56-65. PubMed ID: 22480408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus.
    Han JY; Cho SK; Nam E; Kim H; Lee SS; Jolly M; Sung YK
    Lupus; 2022 Oct; 31(12):1498-1507. PubMed ID: 36017605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
    Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
    J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus.
    Inoue M; Shiozawa K; Yoshihara R; Yamane T; Shima Y; Hirano T; Jolly M; Makimoto K
    Lupus; 2017 Jul; 26(8):849-856. PubMed ID: 27927882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2017 Jul; 44(7):1024-1031. PubMed ID: 28412708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus.
    Harrison MJ; Ahmad Y; Haque S; Dale N; Teh LS; Snowden N; Ho P; Gorodkin R; Bruce IN
    J Rheumatol; 2012 Apr; 39(4):735-42. PubMed ID: 22298908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus.
    Azizoddin DR; Olmstead R; Cost C; Jolly M; Ayeroff J; Racaza G; Sumner LA; Ormseth S; Weisman M; Nicassio PM
    Lupus; 2017 Aug; 26(9):967-974. PubMed ID: 28059025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus.
    Jolly M; Garris CP; Mikolaitis RA; Jhingran PM; Dennis G; Wallace DJ; Clarke A; Dooley MA; Parke A; Strand V; Alárcon GS; Kosinski M
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1542-50. PubMed ID: 24757021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.